Post-earnings recap
Reported
Thu, Oct 26, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock declined by 1.26% following the announcement, likely due to the absence of revenue figures and guidance. Investors may be cautious given the lack of detailed outlook and ongoing market challenges.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.64 | N/A | +0.74% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in their product pipeline while acknowledging external challenges. They are committed to navigating the current market environment.
Management highlighted ongoing demand for their products.
They noted challenges in supply chain but remain focused on innovation.